CGTX vs EQIX · $120.8M cap vs P/E 79, rev $5.07B
Cognition Therapeutics Inc (CGTX) versus Equinix Inc (EQIX) — a side-by-side from cached financials, not a winner call.
Cognition Therapeutics Inc (CGTX) is a biotechnology company listed on US.
Equinix Inc (EQIX) is a reit - specialty company listed on US.
CGTX does not have a complete income-statement cache yet.
Latest reported EQIX revenue for 2026-06-30 was $5.07B. Net income was $894.0M. EQIX currently screens at market cap $74.23B and trailing P/E 79.4.
CGTX currently screens at market cap $120.8M. EQIX currently screens at market cap $74.23B and trailing P/E 79.4.
Not investment advice. Open the CGTX and EQIX stock pages for the full models.
Not investment advice.